GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine
GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive agreement to combine, in which GEDi Cube will become a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition (the “Transaction”). GEDi Cube has been …
GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine Read More »